Dr. Ye has been a principal investigator in the Office of Gene Therapy at FDA’s Center for Biologics Evaluation and Research since 2016. He has a research background in cell engineering and regulatory responsibilities in manufacturing of gene therapy products, with a focus on ex vivo genetically modified cellular therapies.